QBI - Conference

Day 1: Reshaping Science and Health by Collaborating Between Borders and Disciplines



8:30 AM-9:45 AM

QBI and the Scientific Department of the Embassy of France in the United States present, "Reshaping Science and Health by Collaborating Between Borders and Disciplines," a science fair that will take place virtually from November 30–December 3, 2021. This science fair aims to feature different actors from industry, academia, and government from the United States and France to discuss how strengthening the interfaces among experts in different disciplines and countries impacts the progress of healthcare.

Recent progress in health and healthcare has been tremendous, particularly thanks to the massiveness and availability of health data, which is essential as the basis of the future of medicine that can be called "5P": preventive, predictive, participatory, personalized, pertinent. The applications are multiple: aid in diagnosis, analysis of exams, in imaging, discovery of new therapeutic targets and molecules, and more.

This event will bring together different actors to discuss these topics within framework of Franco-American cooperation with the objective to bring together different actors that develop applications for health by crossing disciplines; discuss their impacts and the ethical dimension that accompanies them; form a clear idea of the scientific and technological progress in this area as well as future perspectives; and propose financing solutions to strengthen cooperation between communities of experts, French and American.

November 30, 2021

8:30AM PT, 5:30PM CET - Opening Remarks

Frédéric Jung - Consul General of France in San Francisco

Nevan Krogan - Director of Quantitative Biosciences Institute

Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US

8:45AM PT, 5:45PM CET - A Drug “Sur-mesures”: immunotherapy and the rise of personalized medicine

Immunotherapy is becoming a more and more mature approach for curing a wide range of ailments, from cancers to auto-immune diseases. It is usually based on highly personalized treatments for specific markers and targets. In this panel, specialists will explain how its rise comes from the successful and powerful combination of several disciplines: immunology, statistical analysis, and computer science to name a few.

Moderator: Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US

Aude Chapuis - Associate Professor, Program in Immunology - Clinical Research Division; John C. and Karyl Kay Hughes Endowed Chair, Fred Hutchinson

Julien Mamet - Founder, CSO and Board Member at Adynxx, Inc

Share event by Email

Share event to your friends by email.